Immune Recovery in Adult Patients Following Myeloablative Dual Umbilical Cord Blood, Matched Sibling, and Matched Unrelated Donor Hematopoietic Cell Transplantation

Junya Kanda, MD,1,6,* Lun-Wei Chiou, MD,1,* Paul Szabolcs, MD,2 Gregory D. Sempowski, PhD,3 David A. Rizzieri, MD,1 Gwynn D. Long, MD,1 Keith M. Sullivan, MD,1 Cristina Gasparetto, MD,1 John P. Chute, MD,1 Ashley Morris, PharmD,1 Jacalyn McPherson,1 Jeffrey Hale,3 John Andrew Livingston, MD,1 Gloria Broadwater, MS,4 Donna Niedzwiecki, PhD,5 Nelson J. Chao, MD,1 and Mitchell E. Horwitz, MD1,** 1Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, NC 2Department of Pediatrics, Duke University Medical Center, Durham, NC 3Department of Medicine and Human Vaccine Institute, Duke University School of Medicine, Durham, NC 4Cancer Statistical Center, Duke University Medical Center, Durham, NC 5Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC 6Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan. **Corresponding author: Mitchell E. Horwitz, MD, Division of Cellular Therapy, Department of Medicine, Duke University Medical Center, 2400 Pratt Street, DUMC 3961, Durham, NC 27705, USA. *J.K. and L.C. equally contributed to this work.